Sustained-Release Powders Based on Polymer Particles for Pulmonary Delivery of Beclomethasone Dipropionate in the Treatment of Lung Inflammation

Sustained-Release Powders Based on Polymer Particles for Pulmonary Delivery of Beclomethasone Dipropionate in the Treatment of Lung Inflammation

Inhaled corticosteroids are the mainstay in the management of lung inflammation associated to chronic lung diseases, such as asthma and chronic obstructive pulmonary disease (COPD). Nonetheless, available inhalation products are mostly short-acting formulations that require frequent administrations...

Full description

Bibliographic Details
Main Authors: Emanuela Fabiola Craparo, Salvatore Emanuele Drago, Gabriella Costabile, Maria Ferraro, Elisabetta Pace, Roberto Scaffaro, Francesca Ungaro, Gennara Cavallaro
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Pharmaceutics
Subjects:
polymeric particles
beclomethasone dipropionate (BDP)
α,β-poly(N-2-hydroxyethyl)-D,L-aspartamide (PHEA)
pulmonary administration
inflammation
Online Access:https://www.mdpi.com/1999-4923/15/4/1248

Internet

https://www.mdpi.com/1999-4923/15/4/1248

Similar Items